Logo image of ATRC

ATRICURE INC (ATRC) Stock Fundamental Analysis

NASDAQ:ATRC - Nasdaq - US04963C2098 - Common Stock - Currency: USD

32.2  -0.57 (-1.74%)

After market: 32.2 0 (0%)

Fundamental Rating

4

Overall ATRC gets a fundamental rating of 4 out of 10. We evaluated ATRC against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of ATRC is average, but there are quite some concerns on its profitability. ATRC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ATRC has reported negative net income.
In the past year ATRC had a positive cash flow from operations.
ATRC had negative earnings in 4 of the past 5 years.
In multiple years ATRC reported negative operating cash flow during the last 5 years.
ATRC Yearly Net Income VS EBIT VS OCF VS FCFATRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of ATRC (-6.45%) is better than 65.78% of its industry peers.
ATRC has a Return On Equity of -8.40%. This is in the better half of the industry: ATRC outperforms 67.38% of its industry peers.
Industry RankSector Rank
ROA -6.45%
ROE -8.4%
ROIC N/A
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ATRC Yearly ROA, ROE, ROICATRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Gross Margin, with a value of 74.76%, ATRC belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
In the last couple of years the Gross Margin of ATRC has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ATRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
ATRC Yearly Profit, Operating, Gross MarginsATRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATRC has more shares outstanding
ATRC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ATRC has a worse debt to assets ratio.
ATRC Yearly Shares OutstandingATRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ATRC Yearly Total Debt VS Total AssetsATRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 7.14 indicates that ATRC is not in any danger for bankruptcy at the moment.
ATRC has a better Altman-Z score (7.14) than 85.03% of its industry peers.
ATRC has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
ATRC has a Debt to Equity ratio (0.14) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 7.14
ROIC/WACCN/A
WACC8.84%
ATRC Yearly LT Debt VS Equity VS FCFATRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 4.11 indicates that ATRC has no problem at all paying its short term obligations.
The Current ratio of ATRC (4.11) is better than 66.31% of its industry peers.
A Quick Ratio of 2.88 indicates that ATRC has no problem at all paying its short term obligations.
The Quick ratio of ATRC (2.88) is better than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 4.11
Quick Ratio 2.88
ATRC Yearly Current Assets VS Current LiabilitesATRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

ATRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
Looking at the last year, ATRC shows a quite strong growth in Revenue. The Revenue has grown by 15.79% in the last year.
ATRC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.05% yearly.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)15.79%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%13.57%

3.2 Future

ATRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.98% yearly.
ATRC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.12% yearly.
EPS Next Y22.71%
EPS Next 2Y21.79%
EPS Next 3Y24.41%
EPS Next 5Y24.98%
Revenue Next Year12.84%
Revenue Next 2Y12.73%
Revenue Next 3Y12.85%
Revenue Next 5Y13.12%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ATRC Yearly Revenue VS EstimatesATRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ATRC Yearly EPS VS EstimatesATRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATRC. In the last year negative earnings were reported.
Also next year ATRC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATRC Price Earnings VS Forward Price EarningsATRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATRC Per share dataATRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as ATRC's earnings are expected to grow with 24.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.79%
EPS Next 3Y24.41%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATRC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATRICURE INC

NASDAQ:ATRC (7/1/2025, 4:30:01 PM)

After market: 32.2 0 (0%)

32.2

-0.57 (-1.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners104.13%
Inst Owner Change8.89%
Ins Owners3.45%
Ins Owner Change8.17%
Market Cap1.59B
Analysts85.33
Price Target51.38 (59.57%)
Short Float %3.27%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.94%
Min EPS beat(2)40.06%
Max EPS beat(2)65.82%
EPS beat(4)4
Avg EPS beat(4)30.26%
Min EPS beat(4)0.79%
Max EPS beat(4)65.82%
EPS beat(8)7
Avg EPS beat(8)26.47%
EPS beat(12)9
Avg EPS beat(12)23.59%
EPS beat(16)10
Avg EPS beat(16)63.28%
Revenue beat(2)0
Avg Revenue beat(2)-0.7%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)0%
Revenue beat(4)1
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)1.23%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)6
Avg Revenue beat(12)0.59%
Revenue beat(16)9
Avg Revenue beat(16)1.51%
PT rev (1m)0%
PT rev (3m)-7.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.93%
EPS NY rev (1m)0%
EPS NY rev (3m)13.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.32
P/FCF N/A
P/OCF 71.82
P/B 3.51
P/tB 9.63
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.45
OCFY1.39%
SpS9.7
BVpS9.18
TBVpS3.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.45%
ROE -8.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.76%
FCFM N/A
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.08%
Cap/Sales 4.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.11
Quick Ratio 2.88
Altman-Z 7.14
F-Score5
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y22.71%
EPS Next 2Y21.79%
EPS Next 3Y24.41%
EPS Next 5Y24.98%
Revenue 1Y (TTM)15.79%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%13.57%
Revenue Next Year12.84%
Revenue Next 2Y12.73%
Revenue Next 3Y12.85%
Revenue Next 5Y13.12%
EBIT growth 1Y-10.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year225.62%
EBIT Next 3Y60.95%
EBIT Next 5Y44.31%
FCF growth 1Y96.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1495.85%
OCF growth 3YN/A
OCF growth 5YN/A